EUVD-2025-25453

Malicious code in bioql PyPI...

CVE-2025-53505

Group-Office versions prior to 6.8.119 and prior to 25.0.20 provided by Intermesh BV contain a path traversal vulnerability. If this vulnerability is exploited, information on the server hosting the product may be exposed...

CVE-2025-53505

Group-Office versions prior to 6.8.119 and prior to 25.0.20 provided by Intermesh BV contain a path traversal vulnerability. If this vulnerability is exploited, information on the server hosting the product may be exposed...

CVE-2025-53504

Group-Office versions prior to 6.8.119 and prior to 25.0.20 provided by Intermesh BV contain a cross-site scripting vulnerability. If this vulnerability is exploited, an arbitrary script may be executed in the user's web browser...

CVE-2025-53505

Group-Office versions prior to 6.8.119 and prior to 25.0.20 provided by Intermesh BV contain a path traversal vulnerability. If this vulnerability is exploited, information on the server hosting the product may be exposed...

CVE-2025-53505

Group-Office (Intermesh BV) is affected by a path traversal vulnerability (CVE-2025-53505) in versions prior to 6.8.119 and prior to 25.0.20. The issue can lead to exposure of information on the server hosting the product.root cause: path traversal weakness. Impact: server information disclosure ...

JVN#72111431: Multiple vulnerabilities in Group-Office

Group-Office provided by Intermesh BV contains multiple vulnerabilities listed below. Cross-site scripting CWE-79 CVSS:4.0/AV:N/AC:L/AT:N/PR:L/UI:A/VC:N/VI:N/VA:N/SC:L/SI:L/SA:N Base Score 4.8 CVSS:3.0/AV:N/AC:L/PR:L/UI:R/S:C/C:L/I:L/A:N Base Score 5.4 CVE-2025-53504 Path traversal CWE-22...